S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58
S&P 500   3,900.79
DOW   31,253.13
QQQ   289.58

Cambridge Cognition (COG) Share Forecast, Price & News

GBX 147.50
0.00 (0.00%)
(As of 05/19/2022 09:00 PM ET)
Today's Range
50-Day Range
52-Week Range
5,115 shs
Average Volume
53,065 shs
Market Capitalization
£45.98 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive COG News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter.

Cambridge Cognition logo

About Cambridge Cognition

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Diagnostics & Research
Year Founded

Sales & Book Value

Annual Sales
£10.09 million
Cash Flow
GBX 23.71 per share
Book Value
GBX 2 per share


Pretax Margin




Free Float
Market Cap
£45.98 million

Company Calendar

Last Earnings


Overall MarketRank

0.59 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Cambridge Cognition (LON:COG) Frequently Asked Questions

How were Cambridge Cognition's earnings last quarter?

Cambridge Cognition Holdings Plc (LON:COG) announced its earnings results on Tuesday, September, 22nd. The company reported ($1.50) EPS for the quarter.
View Cambridge Cognition's earnings history

Who are Cambridge Cognition's key executives?
Cambridge Cognition's management team includes the following people:
  • Dr. Matthew Stork, CEO & Director
  • Mr. John Hammond, Co-Founder
  • Mr. Stephen Symonds, CFO & Director
  • Mr. Nick Taptiklis, Head of Technology Strategy
  • Ms. Francesca Cormack Ph.D., Chief Scientist
  • Mr. Simon Merritt, Marketing and Communications Director
  • Dr. Lisa Elizabeth Nolan, VP Bus. Devel. (Age 60)
  • Ms. Nicky Ackerley, Global HR Director
  • Prof. Trevor Robbins, Sr. Consultant
  • Prof. Barbara Sahakian FMedSci, FBPsS, Sr. Consultant
What other stocks do shareholders of Cambridge Cognition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB), Syneos Health (SYNH), Travelers Companies (TRV), Amryt Pharma (AMYT) and AltynGold (ALTN).

What is Cambridge Cognition's stock symbol?

Cambridge Cognition trades on the London Stock Exchange (LON) under the ticker symbol "COG."

How do I buy shares of Cambridge Cognition?

Shares of COG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cambridge Cognition's stock price today?

One share of COG stock can currently be purchased for approximately GBX 147.50.

How much money does Cambridge Cognition make?

Cambridge Cognition has a market capitalization of £45.98 million and generates £10.09 million in revenue each year.

How many employees does Cambridge Cognition have?

Cambridge Cognition employs 58 workers across the globe.

What is Cambridge Cognition's official website?

The official website for Cambridge Cognition is www.cambridgecognition.com.

How can I contact Cambridge Cognition?

Cambridge Cognition's mailing address is Tunbridge Court Tunbridge Lane, Bottisham, CAMBRIDGE, CB25 9TU, United Kingdom. The company can be reached via phone at 44 1223 810 700.

This page was last updated on 5/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.